WannerA, RaoA.Clinical indications for and effects of bland, mucolytic and antimicrobial aerosols. Am Rev Respir Dis1980;122(5, Part 2):79–87.
2.
BrainJ.Aerosol and humidity therapy. Am Rev Respir Dis1980;122:17–21.
3.
DantzkerDD, . Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Official statement of the ATS. Chapter 5, Am Thoracic Society, Nov1986.
4.
KacmarekRM. Humidity and aerosol therapy. In: PiersonDJ, KacmarekRM, eds. Foundations of respiratory care. New York: Churchill Livingstone, 1992:793–824.
5.
RosenbluthM, ChernickV.Influence of mist tent therapy on sputum viscosity and water content in cystic fibrosis. Arch Dis Child1974;49:606–610.
6.
FosterWM, BergofskyEH, BohningDE, LippmannM, AlbertRE. Effect of adrenergic agents and their mode of action on mucociliary clearance in man. J Appl Physiol1976;41:146–152.
7.
BarkerR, LevisonH.Effects of ultrasonically nebulized distilled water on airway dynamics in children with cystic fibrosis and asthma. J Pediatr1972;80:396–400.
8.
CheneyFWJr, ButlerJ.The effects of ultrasonically-produced aerosols on airway resistance in man. Anesthesiology1968;29:1099–1106.
9.
WaltemathCL, BergmanNA. Increased respiratory resistance provoked by endotracheal administration of aerosols. Am Rev Respir Dis1973;108:520–525.
10.
MalikSK, JenkinsDE. Alterations in airway dynamics following inhalation of ultrasonic mist. Chest1972;62:660–664.
11.
CheneyFW, ButlerJ.The effects of ultrasonic aerosols on the total respiratory resistance of the intubated patient. Anesthesiology1970;2:456–458.
12.
WardJJ, HelmholzHFJr. Applied humidity and aerosol therapy. In: BurtonG, HodgkinJE, WardJJ, eds. Respiratory care: a guide to clinical practice, 3rd ed. Philadelphia: JB Lippincott, 1991:355–396.
13.
DulfanoMJ, AdlerK, WootenO.Physical properties of sputum. IV. Effects of 100% humidity and water mist. Am Rev Respir Dis1973;107:130–132.
14.
ZamanMK, WootenOJ, SuprahmanyaB, AnkobiahW, FinchPJ, KamholzSL. Rapid noninvasive diagnosis of Pneumocystis carinii from induced liquefied sputum. Ann Intern Med1988;109(1):7–10.
15.
GlennyRW, PiersonDJ. Cost reduction in diagnosing Pneumocystis carinii pneumonia. Sputum induction versus bronchoalveolar lavage as the initial diagnostic procedure. Am Rev Respir Dis1992;145(6):1425–1428.
16.
FortunJ, NavasE, Marti-BeldaP, MontillaP, HermidaJM, Perez-EliasMJ, . Pneumocystis carinii pneumonia in HIV-infected patients: diagnostic yield of induced sputum and immuno-fluorescent stain with monoclonal antibodies. Eur Respir J1992;5(6):665–669.
17.
Centers for Disease Control. Update: Universal Precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings. MMWR1988;37:377–388.
18.
Centers for Disease Control. Guidelines for preventing the transmission of tuberculosis in health-care settings, with special focus on HIV-related issues. MMWR1990;39(RR-17):1–29.
19.
BradyMT. Nosocomial Legionnaires disease in a children's hospital. J Pediatr1989;115(1):46–50.
20.
MastroTD, FieldsBS, BreimanRF, CampbellJ, PlikaytisBD, SpikaJS. Nosocomial Legionnaires' disease and use of medication nebulizers. J Infect Dis1991;163(3):667–671.